Vascular Diseases Clinical Trial
— COSMOSOfficial title:
Comparison of a Short Compression Hosiery (Stocking Without a Foot) With Standard Compression Stockings After Radiofrequency Ablation of Great Saphenous Vein With Phlebectomy: a Multicenter Randomized Controlled Non-inferiority Trial
Verified date | April 2020 |
Source | Pirogov Russian National Research Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A prospective comparative randomized multicentre non-inferiority trial. The purpose of this study is to compares of a short compression hosiery (stocking without a foot, compression class 2) with standard compression class 2 stockings for 7 days after the endovascular radiofrequency ablation of great saphenous vein with phlebectomy varicose tributaries.
Status | Completed |
Enrollment | 187 |
Est. completion date | December 29, 2018 |
Est. primary completion date | December 29, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Adults over 18 years of age - Symptomatic great saphenous vein (GSV) vein reflux > 0.5 seconds on color Duplex - CEAP C2-C4 (inclusive) - Informed consent Exclusion Criteria: - Symptomatic small saphenous vein (SSV) vein reflux - CEAP Class C5 or C6 disease - Prior GSV treatment - History of deep vein thrombosis - Acute deep or superficial vein thrombosis - Pregnancy - Patients who are unable to attend the hospital for follow-up |
Country | Name | City | State |
---|---|---|---|
Russian Federation | The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation | Moscow | |
Russian Federation | Medalp Private Surgery Clinic | Saint Petersburg | |
Russian Federation | Road Clinical Hospital of JSC "Russian Railways" | Saint Petersburg |
Lead Sponsor | Collaborator |
---|---|
Pirogov Russian National Research Medical University | Medalp Private Surgery Clinic, Research Clinical Centre of the Russian Railways, JSC |
Russian Federation,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Foot swelling | Circumference of the foot | 1, 7, 14, 21, 30 days | |
Primary | Quality of life score measured by CIVIQ20 questionnaire | The specific quality of life score using the Chronic Venous Insufficiency Questionnaire (CIVIQ) score Calculation of the Global Index Score (GIS) of CIVIQ-20 There are 20 questions in the CIVIQ-20, each with 5 possible answers (1 to 5), the minimum possible score being 20 and the maximum 100. In order to calculate the GIS, the difference between the final score and the minimum possible score is to be divided by the difference between the theoretical maximum and minimum scores (100-20=80), multiplied by 100. |
30 days | |
Secondary | Pain level | Patient's post-procedure pain score using a visual analogue scale (VAS) Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. The following cut points on the pain VAS have been recommended: no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm). |
1, 7, 14, 21, 30 days | |
Secondary | Comfort of using compression hosiery | Comfort of using compression hosiery on a visual analogue scale (VAS) Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "comfort" anchor and the patient's mark, providing a range of scores from 0-100. The following cut points on the comfort VAS have been recommended: comfort (0-4 mm), mild comfort (5-44 mm), moderate comfort (45-74 mm), and no comfort (75-100 mm). |
1, 7, 14, 21, 30 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05971407 -
The Effect of Chronic Remote Ischaemic Preconditioning on Blood Pressure in Older Adults
|
N/A | |
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Recruiting |
NCT04390672 -
Multivessel TALENT
|
N/A | |
Recruiting |
NCT04584632 -
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
|
N/A | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Completed |
NCT01684826 -
X-ray Dose Reduction Study for Cardiac Angiography and Intervention
|
N/A | |
Completed |
NCT01417910 -
Predictors of Post Operative Outcome in Peripheral Vascular Surgical Patients
|
N/A | |
Terminated |
NCT00935766 -
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
|
Phase 3 | |
Unknown status |
NCT01748383 -
The Long-term and Short-term Efficacy and Safety of Transplantation Autologous Bone Marrow Cells (BMCs) in Patients With the First STEMI (ST Segment Elevation Myocardial Infarction)
|
Phase 2 | |
Recruiting |
NCT05907564 -
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
|
N/A | |
Recruiting |
NCT03732612 -
Inflammation in Vascular Disease
|
||
Completed |
NCT00000614 -
Prevention of Recurrent Venous Thromboembolism (PREVENT)
|
Phase 3 | |
Completed |
NCT00000479 -
Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
|
Phase 3 | |
Completed |
NCT00000539 -
Arterial Disease Multifactorial Intervention Trial (ADMIT)
|
Phase 3 | |
Completed |
NCT00000530 -
Raynaud's Treatment Study (RTS)
|
Phase 3 | |
Completed |
NCT00000474 -
Prevention and Treatment of Hypertension Study (PATHS)
|
Phase 3 | |
Completed |
NCT00000528 -
Trials of Hypertension Prevention (TOHP)
|
Phase 3 | |
Completed |
NCT00000509 -
Potassium and Sodium to Control Blood Pressure in Hypertensives
|
Phase 3 | |
Completed |
NCT00000501 -
Hypertension Prevention Trial (HPT) Feasibility Study
|
Phase 2 | |
Completed |
NCT00000499 -
Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
|
Phase 2 |